These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8944939)

  • 21. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution.
    Kalya AV; Tector AJ; Crouch JD; Downey FX; McDonald ML; Anderson AJ; Bartoszewski CJ; Hosenpud JD
    J Heart Lung Transplant; 2005 Nov; 24(11):1973-5. PubMed ID: 16297807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantation technique for the Novacor left ventricular assist system.
    Pennington DG; McBride LR; Swartz MT
    J Thorac Cardiovasc Surg; 1994 Oct; 108(4):604-8. PubMed ID: 7934091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic parameters influencing clinical performance of Novacor left ventricular assist system.
    Miyamoto Y; Kormos RL; Borovetz HS; Gaisor T; Pristas JM; Armitage JM; Hardesty RL; Griffith BP
    Artif Organs; 1990 Dec; 14(6):454-7. PubMed ID: 2281995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Univentricular support results in reduction of pulmonary resistance and improved right ventricular function.
    Gallagher RC; Kormos RL; Gasior T; Murali S; Griffith BP; Hardesty RL
    ASAIO Trans; 1991; 37(3):M287-8. PubMed ID: 1751153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
    Shuhaiber J; Hur K; Gibbons R
    J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term mechanical circulatory support with the wearable Novacor left ventricular assist system.
    Loisance DY; Jansen PG; Wheeldon DR; Portner PM
    Eur J Cardiothorac Surg; 2000 Aug; 18(2):220-4. PubMed ID: 10925233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart transplantation versus continuous-flow left ventricular assist device: comprehensive cost at 1 year.
    Patel SR; Sileo A; Bello R; Gunda S; Nguyen J; Goldstein D
    J Card Fail; 2015 Feb; 21(2):160-6. PubMed ID: 25433361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.
    Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A
    Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary.
    Morales DL; Catanese KA; Helman DN; Williams MR; Weinberg A; Goldstein DJ; Rose EA; Oz MC
    J Thorac Cardiovasc Surg; 2000 Feb; 119(2):251-9. PubMed ID: 10649200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical circulatory support with the Novacor LVAS: world-wide clinical results.
    Murali S
    Thorac Cardiovasc Surg; 1999 Feb; 47 Suppl 2():321-5. PubMed ID: 10218609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable ventricular assist devices: is it time to introduce them in Canada?
    McGregor M
    Can J Cardiol; 2000 May; 16(5):629-40. PubMed ID: 10833542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomedical engineering management of Novacor left ventricular assist system (LVAS) patients.
    Pristas JM; Borovetz HS; Kormos RL; Griffith BP
    Perfusion; 1990; 5(3):181-91. PubMed ID: 10149488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The logistics and cost-effectiveness of circulatory support: advantages of the ABIOMED BVS 5000.
    Couper GS; Dekkers RJ; Adams DH
    Ann Thorac Surg; 1999 Aug; 68(2):646-9. PubMed ID: 10475464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life outcomes in left ventricular assist system inpatients and outpatients.
    Dew MA; Kormos RL; Winowich S; Nastala CJ; Borovetz HS; Roth LH; Sanchez J; Griffith BP
    ASAIO J; 1999; 45(3):218-25. PubMed ID: 10360727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of human cardiac myocyte dimension during prolonged mechanical support.
    Jacquet L; Zerbe T; Stein KL; Kormos RL; Griffith BP
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):256-9. PubMed ID: 1992235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of biventricular cardiac function in patients with a Novacor left ventricular assist device.
    Charron M; Follansbee W; Ziady GM; Kormos RL
    J Heart Lung Transplant; 1994; 13(2):263-7. PubMed ID: 8031809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory intraaortic balloon pump use as bridge to heart transplant.
    Cochran RP; Starkey TD; Panos AL; Kunzelman KS
    Ann Thorac Surg; 2002 Sep; 74(3):746-51; discussion 751-2. PubMed ID: 12238834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Out-of-hospital experience in patients with implantable mechanical circulatory support: present and future trends.
    Fey O; El-Banayosy A; Arosuglu L; Posival H; Körfer R
    Eur J Cardiothorac Surg; 1997 Apr; 11 Suppl():S51-3. PubMed ID: 9271182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost and reimbursement rates for investigational circulatory support.
    Swartz MT; Reedy JE; Lohmann D; Bennett T; McBride LR; Pennington DG
    ASAIO Trans; 1991; 37(4):549-52. PubMed ID: 1768486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.